Generate Biomedicines, Inc. (GENB) income statement
GENBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$9.54−0.83 (-8.00%)
Close on Nov 20, 2026Market cap $1.22BP/E –Yield –
Generate Biomedicines, Inc. financial ratios
See a number that looks wrong?